Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Some of the abandon leads and various shapes and positions on the wires from the study. None of these patients had any safety issues related the abandoned leads. Image courtesy of RSNA

MRI in patients with abandoned pacemaker and ICD leads

Abandoned metal wire leads for pacemakers and ICDs did not present a serious safety issue in a study of 80 patients, but a handful of patients did experience a significant change in the composite of capture threshold, sensing or lead impedance.

Anne Kroman, DO, MUSC, explains efforts to increasing female representation in electrophysiology. #GLOWE #HRS #HRS24 #WomeninEP

Efforts to get more women involved in electrophysiology and why it is important

Anne Kroman, DO, PhD, assistant professor at Medical University of South Carolina (MUSC), explains mentoring efforts for women in EP and why it is important for patients to see more female electrophysiologists to help overcome barriers.

Newsweek ranked the 50 best heart hospitals in the world

Leadless vs. transvenous pacemakers after TAVR: Tracking complications, costs and survival

Leadless pacemakers may be an "attractive alternative" to transvenous devices when cardiologists treat older TAVR patients who experience conduction disorders.

Cordis has received U.S. Food and Drug Administration (FDA) approval for its new MYNX Control Venous Vascular Closure Device (VCD) for 6F-12F access sites. The company hopes to launch the newly approved extravascular closure device in the months ahead.

Cordis gains FDA approval for new closure device, inks pricing deal with Premier

The newly approved extravascular closure device was designed for procedures with access sites from 6 to 12 French. It uses the same proprietary GRIP technology found in other Cordis interventional devices.

Healthcare salaries and compensation

Compensation keeps climbing in cardiology, electrophysiology, heart surgery

Among general cardiologists, compensation increased nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps.

Jason Wasfy, MD, associate professor at the Harvard Medical School and director of quality and outcomes research, Massachusetts General Hospital Heart Center, spoke at the Heart Rhythm Society 2024 meeting in the business of cardiology sessions about the current and future models of value based payments.

Value-based care gives cardiology practices an opportunity to thrive

Value-based payments can impact cardiology practices in many ways, helping cardiologists acquire new technology and boost patient care.

Pulse Biosciences nanosecond PFA pulsed field ablation system

FDA grants nanosecond PFA system its breakthrough device designation

The new-look PFA system from Pulse Biosciences was designed to treat AFib with a single application that lasts less than two seconds.

cardiologist viewing heart data

Pulsed field ablation safe for AFib patients, large new study confirms

Electrophysiology specialist Vivek Reddy, MD, and colleagues reviewed data from more than 17,000 patients, presenting their findings in Nature Medicine.